GLYCOBIOLOGY

Scope & Guideline

Exploring the Intricacies of Glycan Structures

Introduction

Welcome to the GLYCOBIOLOGY information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of GLYCOBIOLOGY, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN0959-6658
PublisherOXFORD UNIV PRESS INC
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1990 to 2024
AbbreviationGLYCOBIOLOGY / Glycobiology
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressJOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513

Aims and Scopes

The journal 'GLYCOBIOLOGY' focuses on the intricate roles of glycans in biological systems, emphasizing their structural, functional, and therapeutic implications. The journal publishes research that advances the understanding of glycan biology, glycosylation processes, and their relevance in health and disease.
  1. Glycan Structure and Function:
    Research exploring the structural diversity of glycans and their functional implications in biological processes, including cell signaling, immune responses, and pathogen interactions.
  2. Glycosylation Mechanisms:
    Studies detailing the enzymatic processes involved in glycosylation, including the roles of glycosyltransferases and glycosidases in adding or modifying glycan structures.
  3. Glycans in Disease Mechanisms:
    Investigations into how aberrant glycosylation patterns contribute to disease pathology, including cancer, autoimmune disorders, and infectious diseases.
  4. Therapeutic Applications of Glycans:
    Research on the use of glycosylation as a target for therapeutic interventions, including drug design, vaccine development, and biomarker discovery.
  5. Innovative Glycan Analysis Techniques:
    Development and application of novel methodologies for glycan analysis, including mass spectrometry, glycan microarrays, and bioinformatics tools.
  6. Glycan-Binding Proteins:
    Studies focusing on the interactions between glycans and glycan-binding proteins (lectins, antibodies), elucidating their roles in cellular recognition and signaling.
The journal 'GLYCOBIOLOGY' has observed notable trends and emerging themes that reflect the evolving landscape of glycobiology research. These trends highlight the increasing complexity and significance of glycan interactions in various biological contexts.
  1. Glycans in Immunotherapy:
    There has been a significant increase in research focusing on the role of glycans in modulating immune responses, particularly in the context of cancer immunotherapy and vaccine development.
  2. Glycoengineering:
    Emerging studies emphasize the engineering of glycan structures for therapeutic purposes, including the design of glyco-conjugate vaccines and modified therapeutic antibodies to enhance efficacy.
  3. Glycobiology of Infectious Diseases:
    Research on the interactions between host glycans and pathogens, particularly in the context of COVID-19, has surged, reflecting the urgent need to understand these dynamics for therapeutic interventions.
  4. Glycans in Neurological Disorders:
    Increasing attention is being paid to the roles of glycans in neurodegenerative diseases and mental health disorders, with studies exploring their impact on neuronal signaling and pathology.
  5. AI and Machine Learning in Glycomics:
    The application of artificial intelligence and machine learning techniques to analyze glycan data and predict glycosylation patterns is an emerging trend, facilitating more efficient glycomic studies.
  6. Glycan-Binding Protein Research:
    Research on the discovery and characterization of novel glycan-binding proteins, including their roles in cell recognition and signaling, is on the rise, highlighting their potential therapeutic applications.

Declining or Waning

While 'GLYCOBIOLOGY' continues to thrive in many areas, certain themes have seen a decline in focus over recent years. This shift may reflect changing research priorities or advancements in methodology that have rendered some topics less prominent.
  1. Basic Glycan Chemistry:
    Research that strictly focuses on fundamental glycan chemistry without application to biological systems has become less frequent, as the field shifts towards more applied and translational studies.
  2. Non-Specific Glycan Interaction Studies:
    Papers that explore generalized glycan interactions without specific biological contexts or applications are declining, as the emphasis has moved towards understanding specific mechanisms and implications in health and disease.
  3. Historical Reviews and Methodologies:
    The publication of historical reviews or methodological discussions, while still relevant, has decreased as the journal prioritizes original research findings and innovative studies.
  4. Glycan Studies in Invertebrates:
    Research focusing on glycans from non-mammalian species, particularly invertebrates, has seen a reduction in frequency, possibly due to a shift towards mammalian and clinical relevance.

Similar Journals

Protein & Cell

Shaping the Future of Scientific Collaboration and Discussion
Publisher: OXFORD UNIV PRESSISSN: 1674-800XFrequency: 12 issues/year

Protein & Cell, published by Oxford University Press, is a distinguished international journal focusing on cutting-edge research in the fields of biochemistry, biotechnology, cell biology, and drug discovery. This open access journal, active since 2014, is dedicated to disseminating innovative findings that advance our understanding of protein functions and cellular processes, making it an essential resource for researchers, professionals, and students alike. With an impressive 2023 impact factor reflected in its Q1 ranking across multiple categories such as Biochemistry, Drug Discovery, and Cell Biology, 'Protein & Cell' stands at the forefront of scientific research, driving collaboration and discussion in the scientific community. Researchers can access the journal freely online, fostering a global exchange of knowledge and contributing to significant advancements in medicine and biotechnology. Located in the United Kingdom, the journal strives to be a pivotal platform for impactful research that influences future studies and applications.

CELLULAR SIGNALLING

Illuminating Pathways in Biochemistry and Genetics
Publisher: ELSEVIER SCIENCE INCISSN: 0898-6568Frequency: 12 issues/year

CELLULAR SIGNALLING, published by Elsevier Science Inc, is a premier journal within the realm of Cell Biology, boasting an impressive Q2 category ranking as of 2023. With an ISSN of 0898-6568 and an E-ISSN of 1873-3913, the journal has established itself as a critical platform for advancing the understanding of cellular mechanisms and signal transduction pathways since its inception in 1989. Covering a vast array of topics in Biochemistry, Genetics, and Molecular Biology, it ranks notably at 87 out of 285 in the Scopus list, placing it in the 69th percentile among its peers. The journal serves as an invaluable resource for researchers, professionals, and students seeking high-quality, impactful studies that drive forward the field of cellular biology. While it operates under traditional subscription access, its highlights include rigorous peer-reviewed articles, reviews, and insights that continue to shape current scientific discourse.

Biochemistry and Cell Biology

Fostering collaboration and knowledge in the heart of biochemistry and cell biology.
Publisher: CANADIAN SCIENCE PUBLISHINGISSN: 0829-8211Frequency: 6 issues/year

Biochemistry and Cell Biology, published by Canadian Science Publishing, is a prestigious journal that has been instrumental in advancing the fields of biochemistry, molecular biology, and cell biology since its inception in 1986. With an impressive scope spanning innovative research findings to comprehensive reviews, this journal serves as a vital resource for researchers, professionals, and students alike. Currently positioned in the Q2 quartile in Biochemistry and Q3 quartiles in both Cell Biology and Molecular Biology, it reflects a robust contribution to scientific discourse, placing it among reputable publications in its field. The journal boasts notable rankings within the Scopus database, highlighting its impact and relevance, and continues to be a valuable platform for disseminating pivotal research. By providing access to a wide array of articles, the journal remains committed to fostering knowledge and collaboration in the scientific community.

CELLULAR AND MOLECULAR BIOLOGY

Unveiling the Secrets of Biochemical Processes
Publisher: C M B ASSOCISSN: 0145-5680Frequency: 8 issues/year

Cellular and Molecular Biology is a prominent academic journal published by C M B ASSOC, specializing in the dynamic fields of cellular and molecular biology. Established in 1977, this journal has consistently aimed to disseminate groundbreaking research that contributes to our understanding of biochemical processes, cell dynamics, and molecular mechanisms governing life. With its ISSN 0145-5680 and E-ISSN 1165-158X, the journal plays a vital role in the exchange of innovative ideas, evidenced by its coverage of research from 1977 to 2024. Although currently categorized in the Q4 quartile for major disciplines such as Biochemistry and Cell Biology, it is dedicated to fostering the development of the field by welcoming submissions that challenge the conventional understanding and lead to novel insights. Researchers and academics looking to contribute to or stay updated in the rapidly evolving landscape of molecular biology will find this journal a valuable resource for connecting with a global community of scientists.

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY

Exploring the Frontiers of Pathological Research
Publisher: WILEYISSN: 0959-9673Frequency: 6 issues/year

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, published by Wiley, is a leading peer-reviewed journal dedicated to the field of experimental pathology. With an ISSN of 0959-9673 and E-ISSN 1365-2613, the journal has been a vital resource for researchers and professionals since its inception in 1990, covering a broad spectrum of topics within pathology, cell biology, and molecular biology. The journal's relevancy is underscored by its Q2 ranking in Pathology and Forensic Medicine and Q3 rankings in both Cell Biology and Molecular Biology, as of 2023, reflecting its significant contribution to the scientific community. Although it does not currently offer open access options, readers can benefit from its insightful research articles and reviews that guide advancements in diagnostic pathology and therapeutic strategies. As the journal continues to evolve, it remains committed to facilitating the exchange of innovative ideas and findings that drive progress in experimental pathology and related fields, making it an indispensable platform for scientists, clinicians, and students alike.

JOURNAL OF CELL SCIENCE

Pioneering discoveries in the realm of cell science.
Publisher: COMPANY BIOLOGISTS LTDISSN: 0021-9533Frequency: 24 issues/year

JOURNAL OF CELL SCIENCE, with ISSN 0021-9533 and E-ISSN 1477-9137, is a distinguished publication in the field of Cell Biology, released by COMPANY BIOLOGISTS LTD in the United Kingdom. Since its inception in 1966, this journal has served as a vital platform for disseminating cutting-edge research and reviews that significantly advance our understanding of cellular processes and innovations. Currently positioned in the Q1 category within the 2023 rankings, this journal is recognized for its high impact and quality, holding a notable Scopus rank of 120 out of 285 in the Cell Biology category, placing it within the 58th percentile. While not an open-access journal, it provides extensive access options for readers and institutions, ensuring that pivotal research is accessible to a wide audience. With converged publication years leading toward 2024, JOURNAL OF CELL SCIENCE continues to be an essential resource for researchers, professionals, and students alike, fostering a deeper understanding of the intricate workings of cell biology.

BIOSCIENCE REPORTS

Pioneering Insights in Biophysics and Molecular Biology
Publisher: PORTLAND PRESS LTDISSN: 0144-8463Frequency: 6 issues/year

BIOSCIENCE REPORTS, published by Portland Press Ltd, is a prestigious journal dedicated to advancing the fields of biochemistry, biophysics, cell biology, and molecular biology. Founded in 1981, the journal has established itself as a vital resource for researchers and professionals, boasting a significant impact factor and high rankings within its categories, including Q2 in Biochemistry and Q1 in Biophysics as of 2023. The journal’s commitment to high-quality, peer-reviewed research ensures that it remains an influential platform for the dissemination of cutting-edge scientific findings. While it operates under a traditional subscription model, it offers various access options to accommodate the needs of the scientific community. With ongoing publication through 2024, BIOSCIENCE REPORTS continues to play a crucial role in shaping discussions in the life sciences and fostering innovative research in biology.

FEBS LETTERS

Pioneering New Ideas in Biochemistry and Genetics
Publisher: WILEYISSN: 0014-5793Frequency: 24 issues/year

FEBS LETTERS, published by Wiley, is a prestigious journal that has firmly established its place in the fields of biochemistry, biophysics, genetics, molecular biology, cell biology, and structural biology. With an esteemed history dating back to 1968, this journal continues to be a vital resource for researchers and professionals involved in the biological sciences. It boasts impressive quartile rankings, including Q1 statuses in several categories such as Biochemistry and Genetics, reflecting its high impact factor and significant contribution to scientific discourse. FEBS LETTERS provides a platform for innovative findings and critical reviews, fostering the exchange of knowledge and ideas within the scientific community. Although it operates under a subscription model, the journal ensures broad dissemination of groundbreaking research through its rigorous peer-review process. The vibrant discussions encouraged by articles published in FEBS LETTERS aim to inspire current and future generations of scientists to push the boundaries of biological understanding, making it an indispensable resource for anyone dedicated to advancing their knowledge in these dynamic fields.

Journal of Immunology Research

Empowering Research: Your Source for Cutting-Edge Immunology Insights
Publisher: HINDAWI LTDISSN: 2314-8861Frequency:

Journal of Immunology Research, published by HINDAWI LTD, stands as a pivotal open-access journal in the realm of immunology, with a particular emphasis on advancing knowledge in both fundamental and applied aspects of the field. Since its inception in 1990, the journal has committed to the dissemination of high-quality research, earning a respectable impact factor that reflects its significance. Based in Egypt, it provides a platform for researchers from around the world, showcasing innovative studies and reviews that contribute to the understanding of immune system mechanisms. Its 2023 rankings place it in the Q2 category for Immunology and Allergy, and Q1 in the broader category of Medicine (miscellaneous), indicating a strong reputation among its peers. Through its open-access model, the journal promotes wide accessibility of cutting-edge research, catering to researchers, professionals, and students alike. With ambitions that converge through 2024, the Journal of Immunology Research continues to be an essential resource for those seeking to explore the forefront of immunological science.

FOLIA BIOLOGICA

Exploring the Frontiers of Biochemistry and Beyond
Publisher: CHARLES UNIV PRAGUE, FIRST FACULTY MEDICINEISSN: 0015-5500Frequency: 6 issues/year

FOLIA BIOLOGICA, published by Charles University Prague, First Faculty of Medicine, is an esteemed academic journal that has been contributing to the fields of Biochemistry, Cell Biology, Developmental Biology, Genetics, Immunology, and Molecular Biology since its inception in 1961. With an ISSN of 0015-5500, this journal serves as a vital platform for researchers and professionals to disseminate their findings and advance knowledge within these disciplines. Despite its current Category Quartiles ranking in the lower tiers (Q3 and Q4), FOLIA BIOLOGICA continues to provide valued insights and foster scholarly dialogue, particularly in its paralleled fields. The journal is headquartered in Prague, Czech Republic, and operates without Open Access options, which emphasizes its focus on curated, peer-reviewed content essential for academicians and students. By bridging theoretical and practical knowledge, FOLIA BIOLOGICA remains committed to enriching the scientific community and serving as a cornerstone for future research innovations.